[Effects of lamivudine and thymosin alpha1 combination therapy on patients with chronic hepatitis B].
Wu
Fuquan
F
Department of Infectious Diseases, Dongguan Peoples' Hospital, Dongguan, Guangdong 523000, China.
Yu
Honglin
H
Huang
Shaokun
S
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D000077596:Thymalfasin; D013947:Thymosin / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D000998:Antiviral Agents; D019259:Lamivudine; D013947:Thymosin; D000077596:Thymalfasin